Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hisako Matsumoto

Showing results (1-10 of 209) with videos related to

Pageof 21
Sort By:
Respiratory Investigation|December 20, 2021
Bronchiectasis in severe asthma and asthmatic components in bronchiectasisHisako Matsumoto
Arerugi = [Allergy]|August 28, 2018
[TYPE 2 BIOMARKERS IN ADULTS ASTHMA]Hisako Matsumoto
Advances in Experimental Medicine and Biology|May 1, 2019
Roles of Periostin in AsthmaHisako Matsumoto
Arerugi = [Allergy]|June 10, 2026
[KEY POINTS OF THE 2024 REVISION OF THE JAPANESE GUIDELINES FOR ASTHMA PREVENTION AND MANAGEMENT (JGL2024)]Hisako Matsumoto
Respiratory Investigation|March 25, 2020
Role of serum periostin in the management of asthma and its comorbiditiesHisako Matsumoto
Respiratory Investigation|March 23, 2020
Approach to management of chronic cough and chronic airway diseases: "Treatable traits" or correct diagnosis?Hisako Matsumoto
Respiratory Investigation|April 10, 2019
Our obligation to find treatable and untreatable traits in patients with chronic airway diseasesHisako Matsumoto
Arerugi = [Allergy]|August 8, 2012
[Measurement of alveolar nitric oxide levels in the management of asthma]Hisako Matsumoto
Allergology International : Official Journal of the Japanese Society of Allergology|April 25, 2014
Serum periostin: a novel biomarker for asthma managementHisako Matsumoto
Arerugi = [Allergy]|November 16, 2020
[TREATMENT AGAINST Th-2 INFLAMMATION (EXCEPT FOR TREATMENT AGAINST EOSINOPHIL)]Hisako Matsumoto
Pageof 21

Showing results (1-10 of 209) with videos related to

Sort By:
Pageof 21
Respiratory Investigation|December 20, 2021
Bronchiectasis in severe asthma and asthmatic components in bronchiectasisHisako Matsumoto
Arerugi = [Allergy]|August 28, 2018
[TYPE 2 BIOMARKERS IN ADULTS ASTHMA]Hisako Matsumoto
Advances in Experimental Medicine and Biology|May 1, 2019
Roles of Periostin in AsthmaHisako Matsumoto
Arerugi = [Allergy]|June 10, 2026
[KEY POINTS OF THE 2024 REVISION OF THE JAPANESE GUIDELINES FOR ASTHMA PREVENTION AND MANAGEMENT (JGL2024)]Hisako Matsumoto
Respiratory Investigation|March 25, 2020
Role of serum periostin in the management of asthma and its comorbiditiesHisako Matsumoto
Respiratory Investigation|March 23, 2020
Approach to management of chronic cough and chronic airway diseases: "Treatable traits" or correct diagnosis?Hisako Matsumoto
Respiratory Investigation|April 10, 2019
Our obligation to find treatable and untreatable traits in patients with chronic airway diseasesHisako Matsumoto
Arerugi = [Allergy]|August 8, 2012
[Measurement of alveolar nitric oxide levels in the management of asthma]Hisako Matsumoto
Allergology International : Official Journal of the Japanese Society of Allergology|April 25, 2014
Serum periostin: a novel biomarker for asthma managementHisako Matsumoto
Arerugi = [Allergy]|November 16, 2020
[TREATMENT AGAINST Th-2 INFLAMMATION (EXCEPT FOR TREATMENT AGAINST EOSINOPHIL)]Hisako Matsumoto
Pageof 21